The global Pharmaceutical Intermediates market size was valued at US$ 200180 million in 2024 and is forecast to a readjusted size of USD 302650 million by 2031 with a CAGR of 6.2% during review period.
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
This report is a detailed and comprehensive analysis for global Pharmaceutical Intermediates market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Intermediates market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Pharmaceutical Intermediates market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Pharmaceutical Intermediates market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Pharmaceutical Intermediates market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Intermediates
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Intermediates market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Pharmaceutical Intermediates market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
GMP
Non-GMP
麻豆原创 segment by Application
Antibiotics
Antipyretic Analgesics
Vitamins
Others
Major players covered
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Intermediates product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Intermediates, with price, sales quantity, revenue, and global market share of Pharmaceutical Intermediates from 2020 to 2025.
Chapter 3, the Pharmaceutical Intermediates competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Intermediates breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical Intermediates market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Intermediates.
Chapter 14 and 15, to describe Pharmaceutical Intermediates sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Pharmaceutical Intermediates Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 GMP
1.3.3 Non-GMP
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Pharmaceutical Intermediates Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Antibiotics
1.4.3 Antipyretic Analgesics
1.4.4 Vitamins
1.4.5 Others
1.5 Global Pharmaceutical Intermediates 麻豆原创 Size & Forecast
1.5.1 Global Pharmaceutical Intermediates Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pharmaceutical Intermediates Sales Quantity (2020-2031)
1.5.3 Global Pharmaceutical Intermediates Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Pharmaceutical Intermediates Product and Services
2.1.4 Lonza Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Lonza Recent Developments/Updates
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Pharmaceutical Intermediates Product and Services
2.2.4 Catalent Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Catalent Recent Developments/Updates
2.3 Patheon
2.3.1 Patheon Details
2.3.2 Patheon Major Business
2.3.3 Patheon Pharmaceutical Intermediates Product and Services
2.3.4 Patheon Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Patheon Recent Developments/Updates
2.4 Jubilant
2.4.1 Jubilant Details
2.4.2 Jubilant Major Business
2.4.3 Jubilant Pharmaceutical Intermediates Product and Services
2.4.4 Jubilant Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Jubilant Recent Developments/Updates
2.5 Granules
2.5.1 Granules Details
2.5.2 Granules Major Business
2.5.3 Granules Pharmaceutical Intermediates Product and Services
2.5.4 Granules Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Granules Recent Developments/Updates
2.6 Ganesh
2.6.1 Ganesh Details
2.6.2 Ganesh Major Business
2.6.3 Ganesh Pharmaceutical Intermediates Product and Services
2.6.4 Ganesh Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Ganesh Recent Developments/Updates
2.7 Chemcon
2.7.1 Chemcon Details
2.7.2 Chemcon Major Business
2.7.3 Chemcon Pharmaceutical Intermediates Product and Services
2.7.4 Chemcon Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Chemcon Recent Developments/Updates
2.8 BASF
2.8.1 BASF Details
2.8.2 BASF Major Business
2.8.3 BASF Pharmaceutical Intermediates Product and Services
2.8.4 BASF Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 BASF Recent Developments/Updates
2.9 Porton
2.9.1 Porton Details
2.9.2 Porton Major Business
2.9.3 Porton Pharmaceutical Intermediates Product and Services
2.9.4 Porton Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Porton Recent Developments/Updates
2.10 Lianhetech
2.10.1 Lianhetech Details
2.10.2 Lianhetech Major Business
2.10.3 Lianhetech Pharmaceutical Intermediates Product and Services
2.10.4 Lianhetech Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Lianhetech Recent Developments/Updates
2.11 ABA Chem
2.11.1 ABA Chem Details
2.11.2 ABA Chem Major Business
2.11.3 ABA Chem Pharmaceutical Intermediates Product and Services
2.11.4 ABA Chem Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 ABA Chem Recent Developments/Updates
2.12 Tianma
2.12.1 Tianma Details
2.12.2 Tianma Major Business
2.12.3 Tianma Pharmaceutical Intermediates Product and Services
2.12.4 Tianma Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Tianma Recent Developments/Updates
2.13 Jiujiujiu
2.13.1 Jiujiujiu Details
2.13.2 Jiujiujiu Major Business
2.13.3 Jiujiujiu Pharmaceutical Intermediates Product and Services
2.13.4 Jiujiujiu Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Jiujiujiu Recent Developments/Updates
2.14 Alpha
2.14.1 Alpha Details
2.14.2 Alpha Major Business
2.14.3 Alpha Pharmaceutical Intermediates Product and Services
2.14.4 Alpha Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Alpha Recent Developments/Updates
2.15 Jiuzhou
2.15.1 Jiuzhou Details
2.15.2 Jiuzhou Major Business
2.15.3 Jiuzhou Pharmaceutical Intermediates Product and Services
2.15.4 Jiuzhou Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Jiuzhou Recent Developments/Updates
2.16 Yongtai
2.16.1 Yongtai Details
2.16.2 Yongtai Major Business
2.16.3 Yongtai Pharmaceutical Intermediates Product and Services
2.16.4 Yongtai Pharmaceutical Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Yongtai Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Intermediates by Manufacturer
3.1 Global Pharmaceutical Intermediates Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pharmaceutical Intermediates Revenue by Manufacturer (2020-2025)
3.3 Global Pharmaceutical Intermediates Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Pharmaceutical Intermediates by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Pharmaceutical Intermediates Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Pharmaceutical Intermediates Manufacturer 麻豆原创 Share in 2024
3.5 Pharmaceutical Intermediates 麻豆原创: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Intermediates 麻豆原创: Region Footprint
3.5.2 Pharmaceutical Intermediates 麻豆原创: Company Product Type Footprint
3.5.3 Pharmaceutical Intermediates 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharmaceutical Intermediates 麻豆原创 Size by Region
4.1.1 Global Pharmaceutical Intermediates Sales Quantity by Region (2020-2031)
4.1.2 Global Pharmaceutical Intermediates Consumption Value by Region (2020-2031)
4.1.3 Global Pharmaceutical Intermediates Average Price by Region (2020-2031)
4.2 North America Pharmaceutical Intermediates Consumption Value (2020-2031)
4.3 Europe Pharmaceutical Intermediates Consumption Value (2020-2031)
4.4 Asia-Pacific Pharmaceutical Intermediates Consumption Value (2020-2031)
4.5 South America Pharmaceutical Intermediates Consumption Value (2020-2031)
4.6 Middle East & Africa Pharmaceutical Intermediates Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Pharmaceutical Intermediates Sales Quantity by Type (2020-2031)
5.2 Global Pharmaceutical Intermediates Consumption Value by Type (2020-2031)
5.3 Global Pharmaceutical Intermediates Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Pharmaceutical Intermediates Sales Quantity by Application (2020-2031)
6.2 Global Pharmaceutical Intermediates Consumption Value by Application (2020-2031)
6.3 Global Pharmaceutical Intermediates Average Price by Application (2020-2031)
7 North America
7.1 North America Pharmaceutical Intermediates Sales Quantity by Type (2020-2031)
7.2 North America Pharmaceutical Intermediates Sales Quantity by Application (2020-2031)
7.3 North America Pharmaceutical Intermediates 麻豆原创 Size by Country
7.3.1 North America Pharmaceutical Intermediates Sales Quantity by Country (2020-2031)
7.3.2 North America Pharmaceutical Intermediates Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Pharmaceutical Intermediates Sales Quantity by Type (2020-2031)
8.2 Europe Pharmaceutical Intermediates Sales Quantity by Application (2020-2031)
8.3 Europe Pharmaceutical Intermediates 麻豆原创 Size by Country
8.3.1 Europe Pharmaceutical Intermediates Sales Quantity by Country (2020-2031)
8.3.2 Europe Pharmaceutical Intermediates Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Intermediates Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pharmaceutical Intermediates Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pharmaceutical Intermediates 麻豆原创 Size by Region
9.3.1 Asia-Pacific Pharmaceutical Intermediates Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pharmaceutical Intermediates Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Pharmaceutical Intermediates Sales Quantity by Type (2020-2031)
10.2 South America Pharmaceutical Intermediates Sales Quantity by Application (2020-2031)
10.3 South America Pharmaceutical Intermediates 麻豆原创 Size by Country
10.3.1 South America Pharmaceutical Intermediates Sales Quantity by Country (2020-2031)
10.3.2 South America Pharmaceutical Intermediates Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Intermediates Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pharmaceutical Intermediates Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pharmaceutical Intermediates 麻豆原创 Size by Country
11.3.1 Middle East & Africa Pharmaceutical Intermediates Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pharmaceutical Intermediates Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Pharmaceutical Intermediates 麻豆原创 Drivers
12.2 Pharmaceutical Intermediates 麻豆原创 Restraints
12.3 Pharmaceutical Intermediates Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Pharmaceutical Intermediates and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Intermediates
13.3 Pharmaceutical Intermediates Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Intermediates Typical Distributors
14.3 Pharmaceutical Intermediates Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
听
听
*If Applicable.
